Radiologists, meanwhile, took to social media to criticize the endeavor, noting that the generative AI company lacks clinical evidence to back its marketing claims.
The proportion of radiologists performing some (>0%) IR-related work declined from 70% in 2008 down to 50% by 2023, according to new research published in JVIR.
BrainBot's development represents a significant step forward for image-guided interventional procedures, as fully robotic neurosurgical devices are not designed to be MRI-compatible.
Its warning pertains to Flexible Cryoprobes, made by Marietta, Georgia-based manufacturer Erbe USA, which may rupture or burst during device activation.
The Columbus, Ohio-based imaging group is repositioning the business to “strengthen brand visibility, clarify service offerings and support long-term growth in an increasingly competitive radiology marketplace.”
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.
